Emergent BioSolutions to Release Fourth Quarter 2021 Financial Results and Conduct Conference Call on February 24, 2022
February 07 2022 - 6:30AM
Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call
on Thursday, February 24, 2022 at 5:00 pm eastern time to discuss
the financial results for the fourth quarter 2021, recent business
developments, financial outlook for full year 2022, and revenue
guidance for the first quarter of 2022.
This conference call can be accessed live by
telephone or by webcast:
Teleconference
Information:Dial in number – toll-free:
(855) 766-6521Dial in number – toll: (262)
912-6157Conference ID: 7619558
Webcast
Information:Visit
https://edge.media-server.com/mmc/p/tfd93ojy for the live
webcast.
A replay of the call can be accessed from the Investors page of
the Emergent website.
About Emergent BioSolutionsAt Emergent, our
mission is to protect and enhance life. We develop, manufacture,
and deliver protections against public health threats through a
pipeline of innovative vaccines and therapeutics. For over 20
years, we’ve been at work defending people from things we hope will
never happen—so that we’re prepared just in case they ever do. We
do what we do because we see the opportunity to create a better,
more secure world. One where preparedness empowers protection from
the threats we face. And peace of mind prevails. In working
together, we envision protecting or enhancing 1 billion lives by
2030. For more information, visit our website and follow us on
LinkedIn, Twitter, and Instagram.
Investor Contact:Robert G.
BurrowsVice President, Investor
Relations240-631-3280burrowsr@ebsi.com
Media Contact:Matt HartwigSenior
Director, Media Relationsmediarelations@ebsi.com
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Jul 2023 to Jul 2024